Merck KGaA secures CRISPR patent in China

26-04-2018

Merck KGaA secures CRISPR patent in China

ralwel / iStockphoto.com

China’s State Intellectual Property Office (SIPO) has granted Merck KGaA a patent covering its CRISPR technology used in a genomic-integration method for eukaryotic cells.


Merck KGaA, CRISPR, genome editing, CRISPR-Cas9, patent, China’s State Intellectual Property Office

LSIPR